Cost-effectiveness of national mandatory screening of all admissions to English National Health Service hospitals for meticillin-resistant Staphylococcus aureus: A mathematical modelling study

The Lancet Infectious Diseases

Volumn 16, Issue 3, 2016, Pages 348-356

  Robotham, Julie V ^a   Deeny, Sarah R ^a   Fuller, Chris ^b   Hopkins, Susan ^c   Cookson, Barry ^b   Stone, Sheldon ^d  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; DISEASE TRANSMISSION; HEALTH CARE POLICY; HIGH RISK PATIENT; HOSPITAL; HOSPITAL ADMISSION; LOW RISK PATIENT; MATHEMATICAL MODEL; MEDICAL DECISION MAKING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NATIONAL HEALTH SERVICE; PATIENT CARE; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; QUALITY ADJUSTED LIFE YEAR; SCREENING TEST; SENSITIVITY ANALYSIS; CLASSIFICATION; COST BENEFIT ANALYSIS; ECONOMICS; ENGLAND; HOSPITALIZATION; HUMAN; ISOLATION AND PURIFICATION; MASS SCREENING; MICROBIOLOGY; PENICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; THEORETICAL MODEL;

ANTIINFECTIVE AGENT; METICILLIN;

ANTI-BACTERIAL AGENTS; COST-BENEFIT ANALYSIS; ENGLAND; HOSPITALIZATION; HOSPITALS; HUMANS; MASS SCREENING; METHICILLIN; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MODELS, THEORETICAL; STAPHYLOCOCCAL INFECTIONS; STATE MEDICINE;

EID: 84959180328     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(15)00417-X     Document Type: Article

References (32)

1. Improving patient care by reducing the risk of hospital acquired infection: a progress report National Audit Office, (accessed Oct 13, 2013). http://antibiotic-action.com/wp-content/uploads/2011/07/NAO-Improving-patient-care-by-reducing-the-risk-of-hospital-acquired-infection-2004.pdf.
2. The management and control of hospital acquired infection in acute NHS trusts in England National Audit Office Comptroller and Auditor General, (accessed Oct 11, 2013). http://www.nao.org.uk/wp-content/uploads/2000/02/9900230.pdf.
3. Coia JE, Duckworth GJ, Edwards DI, et al. Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect 2006, 63(suppl 1):S1-44.
4. The Health Act 2006: code of practice for the prevention and control of health care associated infections Department of Health, (accessed Oct 11, 2013). http://www.rcpath.org/Resources/RCPath/Migrated%20Resources/Documents/M/Health%20Act%202006%20Code%20of%20Practice%20for%20the%20prevention%20and%20control%20of%20healthcare.pdf.
5. Results from the mandatory surveillance of MRSA bacteraemia. Financial year MRSA bacteraemia counts and rates (FY 2001/02-FY 2006/07) Public Health England, (accessed Oct 11, 2013). http://webarchive.nationalarchives.gov.uk/20140714084352/http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/HPAweb_C/1233906819629.
6. Results from the mandatory surveillance of MRSA bacteraemia. Financial year counts and rates of MRSA bacteraemia by NHS acute Trust (FY 2007/08-2011/12) Public Health England, (accessed Oct 11, 2013). http://webarchive.nationalarchives.gov.uk/20140714084352/http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/HPAweb_C/1233906819629.
7. Stone SP, Fuller C, Savage J, et al. Evaluation of the national Cleanyourhands campaign to reduce Staphylococcus aureus bacteraemia and Clostridium difficile infection in hospitals in England and Wales by improved hand hygiene: four year, prospective, ecological, interrupted time series stud. BMJ 2012, 344:e3005.
8. Gopal Rao G, Michalczyk P, Nayeem N, Walker G, Wigmore L Prevalence and risk factors for meticillin-resistant Staphylococcus aureus in adult emergency admissions-a case for screening all patients?. J Hosp Infect 2007, 66:15-21.
9. Hardy K, Price C, Szczepura A, et al. Reduction in the rate of methicillin-resistant Staphylococcus aureus acquisition in surgical wards by rapid screening for colonization: a prospective, cross-over study. Clin Microbiol Infect 2010, 16:333-339.
10. Jeyaratnam D, Whitty CJM, Phillips K, et al. Impact of rapid screening tests on acquisition of meticillin resistant Staphylococcus aureus: cluster randomised crossover trial. BMJ 2008, 336:927-930.
11. Rajan L, Smyth E, Humphreys H Screening for MRSA in ICU patients. How does PCR compare with culture?. J Infect 2007, 55:353-357.
12. Lee BY, Tsui BY, Bailey RR, et al. Should vascular surgery patients be screened preoperatively for methicillin-resistant Staphylococcus aureus?. Infect Control Hosp Epidemiol 2009, 30:1158-1165.
13. Murthy A, De Angelis G, Pittet D, Schrenzel J, Uckay I, Harbarth S Cost-effectiveness of universal MRSA screening on admission to surgery. Clin Microbiol Infect 2010, 16:1747-1753.
14. Robotham JV, Graves N, Cookson BD, et al. Screening, isolation, and decolonisation strategies in the control of meticillin resistant Staphylococcus aureus in intensive care units: cost effectiveness evaluation. BMJ 2011, 343:d5694.
15. Worby CJ, Jeyaratnam D, Robotham JV, et al. Estimating the effectiveness of isolation and decolonization measures in reducing transmission of methicillin-resistant Staphylococcus aureus in hospital general wards. Am J Epidemiol 2013, 177:1306-1313.
16. Cooper BS, Medley GF, Stone SP, et al. Methicillin-resistant Staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes. Proc Natl Acad Sci USA 2004, 101:10223-10228.
17. Hubben G, Bootsma M, Luteijn M, et al. Modelling the costs and effects of selective and universal hospital admission screening for methicillin-resistant Staphylococcus aureus. PLoS One 2011, 6:e14783.
18. Ritchie K, Bradbury I, Eastgate J, et al. The clinical and cost effectiveness of screening for meticillin-resistant Staphylococcus aureus (MRSA). Glasgow: Quality Improvement Scotland (NHS QIS) (accessed Oct 11, 2013). http://www.crd.york.ac.uk/crdweb/ShowRecord.asp?ID=32006000901.
19. NHS Scotland MRSA Screening Pathfinder Programme Health Protection Scotland, (accessed Oct 11, 2013). http://www.hps.scot.nhs.uk/haiic/sshaip/mrsascreeningprogramme.aspx.
20. The Operating framework for 2010/11 for the NHS in England Department of Health, NHS Finance Performance and OperationsNHS Finance Performance and Operations, (accessed Oct 11, 2013). http://www.connectingforhealth.nhs.uk/systemsandservices/infogov/links/operatingframework2010-2011.pdf.
21. Fuller C, Robotham J, Savage J, et al. The national one week prevalence audit of MRSA screening (accessed May 16, 2014). http://www.idrn.org/documents/resources/Final%20report%2028-02-2014.pdf.
22. Fuller C, Robotham J, Savage J, et al. The national one week prevalence audit of universal meticillin-resistant Staphylococcus aureus (MRSA) admission screening 2012. PLoS One 2013, 8:e74219.
23. Robotham J, Graves N, Barnett A, et al. Department of Health report: model-based evaluation and cost-effectiveness analysis of MRSA intervention policies 2011, Department of Health, England.
24. Graves N, Halton K, Lairson D Economics and preventing hospital-acquired infection: broadening the perspective. Infect Control Hosp Epidemiol 2007, 28:178-184.
25. Graves N Economics and preventing hospital-acquired infection. Emerg Infect Dis 2004, 10:561-566.
26. Graves N, Harbarth S, Beyersmann J, Barnett AG, Halton K, Cooper BS Estimating the cost of health care-associated infections: mind your p's and q's. Clin Infect Dis 2010, 50:1017-1021.
27. Rawlins MD, Culyer AJ National Institute for Clinical Excellence and its value judgments. BMJ 2004, 329:224-227.
28. Claxton K, Sculpher M, McCabe C, et al. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. Health Econ 2005, 14:339-347.
29. Otter JA, Herdman MT, Williams B, Tosas O, Edgeworth JD, French GL Low prevalence of meticillin-resistant Staphylococcus aureus carriage at hospital admission: implications for risk-factor-based vs universal screening. J Hosp Infect 2013, 83:114-121.
30. Meyer B, Cookson B Does microbial resistance or adaptation to biocides create a hazard in infection prevention and control?. J Hosp Infect 2010, 76:200-205.
31. Huang SS, Septimus E, Kleinman K, et al. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 2013, 368:2255-2265.
32. Implementation of modified admission MRSA screening guidance for NHS (2014) Department of Health expert advisory committee on Antimicrobial Resistance and Healthcare Associated Infection (ARHAI), (accessed Aug 19, 2015). https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/345144/Implementation_of_modified_admission_MRSA_screening_guidance:for_NHS.pdf.